Lundbeckfond Invest A/S Insider Trades

Insider Trading History

Track insider trading activity for Lundbeckfond Invest A/S. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
IO Biotech
IO Biotech IOBT
10% owner
Holding Value $172k 13,950,686 shares
Last Trade
Aug 09, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$28.4M 15,802,468 shares
$1.80
$0.01
IO Biotech
IO Biotech IOBT
10% owner
Holding Value $48.1k 3,906,595 shares
Last Trade
Nov 09, 2021 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$52M 3,906,595 shares
$13.32
$0.01
IO Biotech
IO Biotech IOBT
10% owner
Holding Value $0 0 shares
Last Trade
Nov 09, 2021 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$4.93M 370,129 shares
$13.32
$0.01
IO Biotech
IO Biotech IOBT
10% owner
Holding Value $0 0 shares
Last Trade
Nov 04, 2021 Sale
No data
No data
$0.01
Imara
Imara IMRA
10% owner
Holding Value $0 0 shares
Last Trade
Mar 16, 2020 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$122M 7,843,685 shares
$15.50
$17.66
Imara
Imara IMRA
10% owner
Holding Value $22M 1,245,222 shares
Last Trade
Mar 16, 2020 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$19.3M 1,245,222 shares
$15.50
$17.66
Imara
Imara IMRA
10% owner
Holding Value $25.3M 1,432,722 shares
Last Trade
Mar 16, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3M 187,500 shares
$16.00
$17.66
Imara
Imara IMRA
10% owner
Holding Value $0 0 shares
Last Trade
Mar 11, 2020 Sale
No data
No data
$17.66
Trevi Therapeutics
Trevi Therapeutics TRVI
10% owner
Holding Value $10.8M 776,544 shares
Last Trade
May 09, 2019 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$6.29M 776,544 shares
$8.10
$13.93
Trevi Therapeutics
Trevi Therapeutics TRVI
10% owner
Holding Value $0 0 shares
Last Trade
May 09, 2019 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$55.5M 6,849,315 shares
$8.10
$13.93
Trevi Therapeutics
Trevi Therapeutics TRVI
10% owner
Holding Value $16M 1,151,544 shares
Last Trade
May 09, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.04M 375,000 shares
$8.10
$13.93
Trevi Therapeutics
Trevi Therapeutics TRVI
10% owner
Holding Value $0 0 shares
Last Trade
May 07, 2019 Sale
$6.13M 776,307 shares
$7.89
$13.93
scPharmaceuticals
scPharmaceuticals SCPH
10% owner
Holding Value $0 0 shares
Last Trade
Nov 21, 2017 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$254M 18,160,328 shares
$14.00
$5.67
scPharmaceuticals
scPharmaceuticals SCPH
10% owner
Holding Value $14.3M 2,529,224 shares
Last Trade
Nov 21, 2017 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$35.4M 2,529,224 shares
$14.00
$5.67
scPharmaceuticals
scPharmaceuticals SCPH
10% owner
Holding Value $18.1M 3,183,986 shares
Last Trade
Nov 21, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$9.17M 654,762 shares
$14.00
$5.67
scPharmaceuticals
scPharmaceuticals SCPH
10% owner
Holding Value $0 0 shares
Last Trade
Nov 16, 2017 Sale
No data
No data
$5.67
Spero Therapeutics
Spero Therapeutics SPRO
10% owner
Holding Value $0 0 shares
Last Trade
Nov 01, 2017 Sale
$1.68M 877,489 shares
$1.92
$2.98
Eiger BioPharmaceuticals
Eiger BioPharmaceuticals EIGR
10% owner
Holding Value $0 0 shares
Last Trade
Feb 04, 2014 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$147M 19,666,185 shares
$7.50
$1.72
Eiger BioPharmaceuticals
Eiger BioPharmaceuticals EIGR
10% owner
Holding Value $2.7M 1,563,002 shares
Last Trade
Feb 04, 2014 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$11.9M 1,591,668 shares
$7.50
$1.72
Eiger BioPharmaceuticals
Eiger BioPharmaceuticals EIGR
10% owner
Holding Value $3.01M 1,745,683 shares
Last Trade
Feb 04, 2014 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.46M 182,681 shares
$8.00
$1.72

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up